Editorial: tackling hepatorenal syndrome-terlipressin for all, or time for a stratified approach?

Affiliations

¹ Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
² MRC Centre for Inflammation Research, Royal Infirmary of Edinburgh, Edinburgh, UK.

Editorial

F J Gifford et al. Aliment Pharmacol Ther. 2017 Jul.

. 2017 Jul;46(2):193-194.

doi: 10.1111/apt.14098.

¹ Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
² MRC Centre for Inflammation Research, Royal Infirmary of Edinburgh, Edinburgh, UK.

No abstract available

Comment on

Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.
Sanyal AJ, Boyer TD, Frederick RT, Wong F, Rossaro L, Araya V, Vargas HE, Reddy KR, Pappas SC, Teuber P, Escalante S, Jamil K. Sanyal AJ, et al. Aliment Pharmacol Ther. 2017 Jun;45(11):1390-1402. doi: 10.1111/apt.14052. Epub 2017 Mar 29. Aliment Pharmacol Ther. 2017. PMID: 28370090 Free PMC article.